glowing
发表于 2025-3-23 10:24:54
http://reply.papertrans.cn/16/1515/151478/151478_11.png
马赛克
发表于 2025-3-23 16:15:32
The RAAS in Heart Failure: An Update on Clinical Trials and Opportunities for Therapy,condition, its medical management remains a challenge, with a significant 5-year mortality. At the present time, treatment of heart failure has centered on the idea that its clinical manifestations are associated with a derangement of the renin-angiotensin-aldosterone system (RAAS) leading eventuall
Locale
发表于 2025-3-23 22:00:15
http://reply.papertrans.cn/16/1515/151478/151478_13.png
ACTIN
发表于 2025-3-23 22:25:24
Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Out (CV) changes with aging predispose the elderly to HF. Comorbidities such as coronary artery disease with ST-segment-elevation myocardial infarction (STEMI) and hypertension (HTN) are more prevalent in the elderly and contribute to the development of HF. Morbidity, hospitalizations, and costs associ
Congeal
发表于 2025-3-24 06:00:12
http://reply.papertrans.cn/16/1515/151478/151478_15.png
绿州
发表于 2025-3-24 06:39:47
http://reply.papertrans.cn/16/1515/151478/151478_16.png
APRON
发表于 2025-3-24 11:40:47
http://reply.papertrans.cn/16/1515/151478/151478_17.png
偶像
发表于 2025-3-24 17:09:21
Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Theradiseases, including myocardial infarction (MI), hypertension (HTN), and HF, are all more prevalent in the elderly. While the renin–angiotensin system (RAS) has critical functions in CV physiology, an upregulated RAS plays a critical role in CV pathophysiology, including post-MI dilative remodeling a
VOK
发表于 2025-3-24 20:13:05
http://reply.papertrans.cn/16/1515/151478/151478_19.png
高调
发表于 2025-3-25 03:05:27
http://reply.papertrans.cn/16/1515/151478/151478_20.png